OSTX Total Liab from 2010 to 2024

OSTX Stock   3.02  1.44  32.29%   
OS Therapies Total Liabilities yearly trend continues to be fairly stable with very little volatility. Total Liabilities will likely drop to about 20 M in 2024. Total Liabilities is the total amount of all liabilities that OS Therapies Incorporated has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2010-12-31
Previous Quarter
24.8 M
Current Value
20 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check OS Therapies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OS Therapies' main balance sheet or income statement drivers, such as Interest Expense of 2.9 M, Selling General Administrative of 1 M or Total Revenue of 0.0, as well as many indicators such as . OSTX financial statements analysis is a perfect complement when working with OS Therapies Valuation or Volatility modules.
  
Check out the analysis of OS Therapies Correlation against competitors.

Latest OS Therapies' Total Liab Growth Pattern

Below is the plot of the Total Liab of OS Therapies Incorporated over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. OS Therapies' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in OS Therapies' overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

OSTX Total Liab Regression Statistics

Arithmetic Mean13,616,470
Geometric Mean13,194,628
Coefficient Of Variation29.58
Mean Deviation2,942,985
Median11,777,104
Standard Deviation4,027,305
Sample Variance16.2T
Range13M
R-Value0.66
Mean Square Error9.8T
R-Squared0.44
Significance0.01
Slope598,278
Total Sum of Squares227.1T

OSTX Total Liab History

202420 M
202324.8 M
202218.1 M

About OS Therapies Financial Statements

OS Therapies investors use historical fundamental indicators, such as OS Therapies' Total Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in OS Therapies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Liabilities24.8 M20 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OSTX Stock Analysis

When running OS Therapies' price analysis, check to measure OS Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OS Therapies is operating at the current time. Most of OS Therapies' value examination focuses on studying past and present price action to predict the probability of OS Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OS Therapies' price. Additionally, you may evaluate how the addition of OS Therapies to your portfolios can decrease your overall portfolio volatility.